Physician profile
Marco Campos
NPI 1487838256
$7,827.27
in general payments reported to CMS, 2019-2025
36 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,970 · 2020: $997 · 2021: $467 · 2022: $1,460 · 2023: $1,163 · 2024: $1,510 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,933.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,409.17 | 2019-2024 | Cardiomems, Aveir, Diamondback Coronary |
| Abiomed | $1,206.04 | 2019-2023 | Impella |
| Janssen Pharmaceuticals, INC | $990.47 | 2019-2021 | |
| Medtronic, INC. | $592.46 | 2021-2025 | Micra, Onyx Frontier, Venaseal |
| Shockwave Medical, INC | $535.98 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $445.27 | 2019-2025 | Repatha, Repatha |
| Irhythm Technologies, INC. | $273.22 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $252.80 | 2020-2023 | Watchman |
| Astrazeneca Pharmaceuticals LP | $243.55 | 2019-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $192.31 | 2019-2025 | |
| Cvrx, INC. | $157.11 | 2022 | |
| Saranas, INC. | $144.56 | 2022 | |
| Canon Medical Systems USA, INC. | $143.24 | 2023 | Interventional Angiography System |
| Esperion Therapeutics, INC. | $140.72 | 2022 | |
| Amarin Pharma, INC. | $124.80 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $115.63 | 2019 | |
| Astellas Pharma US INC | $113.40 | 2019 | |
| Bard Peripheral Vascular, INC. | $111.68 | 2020-2021 | |
| Pfizer INC. | $81.16 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $76.26 | 2019-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.82 | 2019-2022 | |
| Medtronic Vascular, INC. | $61.23 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $53.19 | 2019-2020 | |
| Edwards Lifesciences Corporation | $46.16 | 2019 | |
| Biotronik INC. | $37.22 | 2020 | |
| Tactile Systems Technology INC | $26.82 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Atricure, INC. | $24.01 | 2023 | |
| Chiesi USA, INC. | $23.50 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $20.94 | 2024 | |
| Cardiovascular Systems INC. | $20.73 | 2019 | |
| Kestra Medical Technology Services, INC. | $19.64 | 2025 | Assure Wcd |
| Glaxosmithkline, LLC. | $18.03 | 2025 | Arexvy, Shingrix |
| Actelion Pharmaceuticals US, INC. | $17.87 | 2019 | |
| Scpharmaceuticals INC. | $16.79 | 2024 | |
| Arbor Pharmaceuticals, INC. | $14.75 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Campos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.